The information on this website is limited to the use of sofosbuvir in combination with PEGASYS+ribavirin for the treatment of adult patients with genotype 1 or 4 chronic hepatitis C. The treatment regimen and duration of sofosbuvir are dependent on both viral genotype and patient population. Please refer to the sofosbuvir Full Prescribing Information and Patient Information.
This website is for general educational purposes only and is not intended to convey or be a substitute for the medical advice of your healthcare provider. Your healthcare provider should always be your primary source of information about your health, diagnosis, and treatment.
The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Genentech, Inc. makes no representation as to the accuracy of the information contained on sites we do not own or control. Genentech, Inc. does not recommend and does not endorse the content on any third-party Web sites. Your use of third-party Web sites is at your own risk and subject to the terms and conditions of use for such sites.
The information contained in this section of the site is intended for US healthcare professionals only. Click OK if you are a US healthcare professional.